Blood Profiling Atlas in Cancer (BloodPAC) Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Blood Profiling Atlas in Cancer (BloodPAC)'s estimated annual revenue is currently $1.4M per year.(i)
  • Blood Profiling Atlas in Cancer (BloodPAC)'s estimated revenue per employee is $155,000

Employee Data

  • Blood Profiling Atlas in Cancer (BloodPAC) has 9 Employees.(i)
  • Blood Profiling Atlas in Cancer (BloodPAC) grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M18-14%N/AN/A
#2
$0.8M50%N/AN/A
#3
$2M130%N/AN/A
#4
$707.3M285214%$1.1BN/A
#5
$1.7M110%N/AN/A
#6
$32.6M2106%N/AN/A
#7
$2.6M176%N/AN/A
#8
$1.1M7-30%N/AN/A
#9
$1.4M9-10%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Blood Profiling Atlas in Cancer (BloodPAC)?

Our mandate is to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer. To do so we developed the BloodPAC Data Commons that enables sharing of information between stakeholders in industry, academia, and regulatory agencies.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.7M9N/AN/A
#3
$0.7M9N/AN/A
#4
$0.6M9N/AN/A
#5
$0.9M9N/AN/A